Aminoglycosides Antibiotics Aminoglycosides Antibiotics Market
Aminoglycosides Antibiotics Aminoglycosides Antibiotics Market
The aminoglycosides antibiotics market, worth USD 1.51 billion in 2024, is set to reach USD 2.19 billion by 2034 at a CAGR of 3.8%, fueled by increasing bacterial infection cases and wider therapeutic use.
Report ID: 10454
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 1.51 Bn
Forecast Year,
USD 2.19 Bn
CAGR, 2025 -
3.80%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Aminoglycosides Antibiotics Aminoglycosides Antibiotics Market Size Analysis
Aminoglycosides Antibiotics Aminoglycosides Antibiotics Market Size By Drug 2024 to 2034 (USD )
| Drug | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gentamicin | 0.49 | 0.48 | 0.48 | 0.47 | 0.51 | 0.50 | 0.52 | 0.55 | 0.49 | 0.49 | 0.56 |
| Amikacin | 0.36 | 0.35 | 0.31 | 0.35 | 0.29 | 0.29 | 0.24 | 0.27 | 0.29 | 0.28 | 0.32 |
| Tobramycin | 0.03 | 0.06 | 0.06 | 0.12 | 0.15 | 0.18 | 0.21 | 0.20 | 0.25 | 0.21 | 0.24 |
| Streptomycin | 0.13 | 0.14 | 0.17 | 0.16 | 0.21 | 0.19 | 0.17 | 0.20 | 0.26 | 0.30 | 0.22 |
| Other | 0.50 | 0.54 | 0.61 | 0.59 | 0.59 | 0.66 | 0.76 | 0.74 | 0.75 | 0.83 | 0.86 |
Aminoglycosides Antibiotics Aminoglycosides Antibiotics Market Size By Route 2024 to 2034 (USD )
| Route | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Injectable | 0.42 | 0.46 | 0.49 | 0.45 | 0.43 | 0.48 | 0.45 | 0.45 | 0.48 | 0.55 | 0.65 |
| Oral | 0.75 | 0.74 | 0.78 | 0.80 | 0.84 | 0.83 | 0.92 | 0.98 | 1.02 | 0.99 | 1.01 |
| Topical | 0.34 | 0.37 | 0.36 | 0.44 | 0.48 | 0.51 | 0.52 | 0.53 | 0.54 | 0.57 | 0.53 |
Aminoglycosides Antibiotics Aminoglycosides Antibiotics Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory | 0.61 | 0.64 | 0.70 | 0.72 | 0.76 | 0.73 | 0.78 | 0.88 | 0.92 | 0.93 | 1.01 |
| Urinary Tract | 0.15 | 0.11 | 0.10 | 0.13 | 0.18 | 0.24 | 0.24 | 0.21 | 0.24 | 0.27 | 0.22 |
| Septicemia | 0.05 | 0.10 | 0.09 | 0.10 | 0.09 | 0.10 | 0.11 | 0.06 | 0.08 | 0.08 | 0.11 |
| Other | 0.70 | 0.72 | 0.74 | 0.73 | 0.73 | 0.75 | 0.75 | 0.82 | 0.79 | 0.84 | 0.86 |
Aminoglycosides Antibiotics Aminoglycosides Antibiotics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.30 | 0.26 | 0.30 | 0.29 | 0.28 | 0.26 | 0.23 | 0.22 | 0.22 | 0.21 | 0.16 |
| Europe | 0.24 | 0.28 | 0.29 | 0.26 | 0.28 | 0.31 | 0.42 | 0.43 | 0.43 | 0.41 | 0.46 |
| Asia Pacific | 0.08 | 0.10 | 0.04 | 0.11 | 0.08 | 0.12 | 0.08 | 0.10 | 0.07 | 0.08 | 0.14 |
| Latin America | 0.45 | 0.48 | 0.53 | 0.53 | 0.58 | 0.62 | 0.63 | 0.68 | 0.78 | 0.86 | 0.97 |
| Middle East & Africa | 0.43 | 0.45 | 0.47 | 0.50 | 0.53 | 0.51 | 0.53 | 0.54 | 0.53 | 0.56 | 0.47 |
Aminoglycosides Antibiotics Aminoglycosides Antibiotics Market
Aminoglycosides Antibiotics Aminoglycosides Antibiotics Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
